BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2026)
BioNexus Gene Lab (BGLC) reported Cash from Financing Activities of $59709.0 for Q1 2026, up 7042.91% on a YoY basis from $835.92 in Q1 2025, and down 77.6% sequentially from $266544.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of Cash from Financing Activities data on file, last reported at $59709.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 7042.91% year-over-year to $59709.0; the trailing twelve-month figure through Mar 2026 stood at $359410.0 (up 1609.17% YoY), and the FY2025 full-year result was $298841.0, up 7418.01% from the prior year.
- Cash from Financing Activities retreated to $59709.0 in Q1 2026, from $266544.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $5.7 million in Q3 2023 to a low of -$142387.0 in Q4 2024.
- A 5-year average of $421602.0 and a median of $13035.0 in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 331172.47% in 2023 and plunged 126.78% in 2024, its largest moves.
- Tracing BGLC's Cash from Financing Activities over 5 years: stood at -$2273.0 in 2022, then jumped by 23493.44% to $531733.0 in 2023, then sank by 126.78% to -$142387.0 in 2024, then soared by 287.2% to $266544.0 in 2025, then slumped by 77.6% to $59709.0 in 2026.
- Business Quant data shows BGLC's Cash from Financing Activities at $59709.0 in Q1 2026, $266544.0 in Q4 2025, and $34187.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | -1.97 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 47.60 Mn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | -431.60 Mn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | -101.00 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | -334.00 Mn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | -236.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | -301.00 Mn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | -44.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | 59,709.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,709.00 |
| Mar 31, 2026 | 59,709.00 |
| Dec 31, 2025 | 266,544.00 |
| Dec 31, 2025 | 266,544.00 |
| Sep 30, 2025 | 34,187.00 |
| Sep 30, 2025 | 34,187.00 |
| Jun 30, 2025 | -1,030.00 |
| Jun 30, 2025 | -1,030.00 |
| Mar 31, 2025 | -860.00 |
| Mar 31, 2025 | -860.00 |
| Dec 31, 2024 | -142,387.00 |
| Dec 31, 2024 | -142,387.00 |
| Sep 30, 2024 | -55,982.00 |
| Sep 30, 2024 | -55,982.00 |
| Jun 30, 2024 | 175,414.00 |
| Jun 30, 2024 | 175,414.00 |
| Mar 31, 2024 | 26,930.00 |
| Mar 31, 2024 | 26,930.00 |
| Dec 31, 2023 | 531,733.00 |
| Dec 31, 2023 | 531,733.00 |